Xolegel FDA Approval History
FDA Approved: Yes (First approved July 28, 2006)
Brand name: Xolegel
Generic name: ketoconazole
Dosage form: Gel
Previous Name: Sebazole
Company: Barrier Therapeutics, Inc.
Treatment for: Seborrheic Dermatitis
Xolegel is a topical waterless gel formulation of the antifungal agent ketoconazole, applied once-daily for the treatment of seborrheic dermatitis in immunocompetent adults and children twelve years of age and older.
Development timeline for Xolegel
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
